[Chronic migraine as seen by neurologists and patients: results of the CIEN-mig project (III)].
BACKGROUND
Data on the reality of chronic migraine in our clinics are scarce. AIM. To know the frequency of consultation and attitude of the neurologist regarding chronic migraine, and the opinion of patients with this condition.


METHODS
A total of 145 neurologists consulted electronically two questionnaires. The first tested the impact of chronic migraine and their approach in the daily practice. The second was filled in by the consecutive patients.


RESULTS
A total of 4.1% of patients consulted due to chronic migraine, mostly women in their forties. The average time for diagnosis was 28.7 months. All neurologists recommended preventive treatment from the beginning. More than a quarter kept this treatment for more than a year and used drug combinations. Only half thought that overuse was the reason for chronic migraine and the majority allowed non-steroidal anti-inflammatories and triptans at restricted doses. Only half of the patients knew they had chronic migraine. In their opinion, heredity and the absence of an early and serious treatment could contribute for chronic migraine development.


CONCLUSIONS
Almost one patient per day consults due to chronic migraine, which gives an idea of its impact. A better feed-back with primary care level is necessary, if we consider that the delay in the diagnosis is longer than two years. The majority of neurologists follows the current recommendations of the Headache Group of the Spanish Society of Neurology.
Pascual
Julio
J
Servicios de Neurología, Hospital Universitario Central de Asturias, Oviedo, Asturias. juliopascual@telefonica.net
Sánchez del Río
Margarita
M
Jiménez
María Dolores
MD
Láinez-Andrés
José Miguel
JM
Mateos
Valentín
V
Leira
Rogelio
R
Pozo-Rosich
Patricia
P
Guzmán-Quilo
Carlos
C
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy; D009462:Neurology; D010361:Patients; D010820:Physicians; D010818:Practice Patterns, Physicians'; D012017:Referral and Consultation; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014363:Tryptamines / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D014363:Tryptamines